Get Premium to unlock powerful stock data

HealthInvest Partners AB Buys Harmony Biosciences Holdings Inc, Rigel Pharmaceuticals Inc, Lannett Co Inc, Sells Ironwood Pharmaceuticals Inc, Vertex Pharmaceuticals Inc, Cigna Corp

Author's Avatar
insider
Nov 08, 2021
Article's Main Image
Stockholm, V7, based Investment company HealthInvest Partners AB (Current Portfolio) buys Harmony Biosciences Holdings Inc, Rigel Pharmaceuticals Inc, Lannett Co Inc, Utah Medical Products Inc, Zogenix Inc, sells Ironwood Pharmaceuticals Inc, Vertex Pharmaceuticals Inc, Cigna Corp, McKesson Corp, Bristol-Myers Squibb Co during the 3-months ended 2021Q3, according to the most recent filings of the investment company, HealthInvest Partners AB. As of 2021Q3, HealthInvest Partners AB owns 17 stocks with a total value of $67 million. These are the details of the buys and sells.

For the details of HealthInvest Partners AB's stock buys and sells, go to https://www.gurufocus.com/guru/healthinvest+partners+ab/current-portfolio/portfolio

These are the top 5 holdings of HealthInvest Partners AB
  1. Ironwood Pharmaceuticals Inc (IRWD) - 685,000 shares, 13.40% of the total portfolio. Shares reduced by 54.93%
  2. Supernus Pharmaceuticals Inc (SUPN) - 335,000 shares, 13.38% of the total portfolio. Shares reduced by 36.79%
  3. Accuray Inc (ARAY) - 1,860,000 shares, 11.00% of the total portfolio. Shares reduced by 19.13%
  4. Harmony Biosciences Holdings Inc (HRMY) - 185,000 shares, 10.62% of the total portfolio. New Position
  5. Rigel Pharmaceuticals Inc (RIGL) - 1,765,000 shares, 9.60% of the total portfolio. New Position
New Purchase: Harmony Biosciences Holdings Inc (HRMY)

HealthInvest Partners AB initiated holding in Harmony Biosciences Holdings Inc. The purchase prices were between $25.68 and $38.61, with an estimated average price of $32.22. The stock is now traded at around $42.920000. The impact to a portfolio due to this purchase was 10.62%. The holding were 185,000 shares as of 2021-09-30.

New Purchase: Rigel Pharmaceuticals Inc (RIGL)

HealthInvest Partners AB initiated holding in Rigel Pharmaceuticals Inc. The purchase prices were between $3.5 and $4.5, with an estimated average price of $3.95. The stock is now traded at around $3.235000. The impact to a portfolio due to this purchase was 9.6%. The holding were 1,765,000 shares as of 2021-09-30.

New Purchase: Lannett Co Inc (LCI)

HealthInvest Partners AB initiated holding in Lannett Co Inc. The purchase prices were between $2.91 and $4.83, with an estimated average price of $4.04. The stock is now traded at around $2.209000. The impact to a portfolio due to this purchase was 7.98%. The holding were 1,775,000 shares as of 2021-09-30.

New Purchase: Utah Medical Products Inc (UTMD)

HealthInvest Partners AB initiated holding in Utah Medical Products Inc. The purchase prices were between $84.89 and $97.16, with an estimated average price of $88.29. The stock is now traded at around $104.040000. The impact to a portfolio due to this purchase was 5.84%. The holding were 42,000 shares as of 2021-09-30.

New Purchase: Zogenix Inc (ZGNX)

HealthInvest Partners AB initiated holding in Zogenix Inc. The purchase prices were between $13.11 and $18.46, with an estimated average price of $15.64. The stock is now traded at around $16.011500. The impact to a portfolio due to this purchase was 5.01%. The holding were 220,000 shares as of 2021-09-30.

New Purchase: Aldeyra Therapeutics Inc (ALDX)

HealthInvest Partners AB initiated holding in Aldeyra Therapeutics Inc. The purchase prices were between $7.94 and $11.31, with an estimated average price of $9.2. The stock is now traded at around $9.143400. The impact to a portfolio due to this purchase was 4.08%. The holding were 310,000 shares as of 2021-09-30.

Sold Out: Vertex Pharmaceuticals Inc (VRTX)

HealthInvest Partners AB sold out a holding in Vertex Pharmaceuticals Inc. The sale prices were between $181.39 and $202.99, with an estimated average price of $195.37.

Sold Out: Cigna Corp (CI)

HealthInvest Partners AB sold out a holding in Cigna Corp. The sale prices were between $200.16 and $238.3, with an estimated average price of $217.75.



Here is the complete portfolio of HealthInvest Partners AB. Also check out:

1. HealthInvest Partners AB's Undervalued Stocks
2. HealthInvest Partners AB's Top Growth Companies, and
3. HealthInvest Partners AB's High Yield stocks
4. Stocks that HealthInvest Partners AB keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus